Back
Bolt Biotherapeutics Stock Price Chart
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Sell
31
BOLT
Bolt Biotherapeutics
Last Price:
1.10
Seasonality Move:
-8.97%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BOLT is experiencing slight selling pressure.
Bolt Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.13 | Sell |
| 20-day SMA: | 1.18 | Sell |
| 50-day SMA: | 1.21 | Sell |
| 200-day SMA: | 1.11 | Sell |
| 8-day EMA: | 1.13 | Sell |
| 20-day EMA: | 1.16 | Sell |
| 50-day EMA: | 1.18 | Sell |
| 200-day EMA: | 1.22 | Sell |
Bolt Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 41.68 | Sell |
| Chaikin Money Flow: | -18146 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.1 - 1.34) | Sell |
| Bollinger Bands (100): | (1.05 - 1.25) | Sell |
Bolt Biotherapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Bolt Biotherapeutics Stock
Is Bolt Biotherapeutics Stock a Buy?
- Bolt Biotherapeutics share price is 1.10 while BOLT 8-day simple moving average is 1.13, which is a Sell signal.
- The stock price of BOLT is 1.10 while Bolt Biotherapeutics 20-day SMA is 1.18, which makes it a Sell.
- Bolt Biotherapeutics 50-day simple moving average is 1.21 while BOLT share price is 1.10, making it a Sell technically.
- BOLT stock price is 1.10 and Bolt Biotherapeutics 200-day simple moving average is 1.11, creating a Sell signal.
BOLT Technical Analysis vs Fundamental Analysis
Sell
31
Bolt Biotherapeutics (BOLT)
is a Sell
Is Bolt Biotherapeutics a Buy or a Sell?
-
Bolt Biotherapeutics stock is rated a Sell
The current Bolt Biotherapeutics [BOLT] share price is $1.10. The Score for BOLT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Bolt Biotherapeutics Stock Info
Market Cap:
41.94M
Price in USD:
1.10
Share Volume:
90.73K
Bolt Biotherapeutics 52-Week Range
52-Week High:
2.03
52-Week Low:
0.84
Sell
31
Bolt Biotherapeutics (BOLT)
is a Sell
Bolt Biotherapeutics Share Price Forecast
-
What is the Bolt Biotherapeutics stock price today?
The Bolt Biotherapeutics stock price is 1.10 USD today. -
Will BOLT stock go up or go down?
Bolt Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Bolt Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bolt Biotherapeutics is overvalued.
Is Bolt Biotherapeutics Stock a Buy?
- Bolt Biotherapeutics share price is 1.10 while BOLT 8-day exponential moving average is 1.13, which is a Sell signal.
- The stock price of BOLT is 1.10 while Bolt Biotherapeutics 20-day EMA is 1.16, which makes it a Sell.
- Bolt Biotherapeutics 50-day exponential moving average is 1.18 while BOLT share price is 1.10, making it a Sell technically.
- BOLT stock price is 1.10 and Bolt Biotherapeutics 200-day simple moving average is 1.22, creating a Sell signal.
Fundamental Analysis of Bolt Biotherapeutics
Is Bolt Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.58 per share.
Technical Analysis of Bolt Biotherapeutics
Should I short Bolt Biotherapeutics stock?
- BOLT Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Bolt Biotherapeutics is a Sell
- Bolt Biotherapeutics Relative Strength Index (RSI) is 41.68, which suggest Bolt Biotherapeutics is oversold
- The Bollinger Bands (25) for Bolt Biotherapeutics is (1.1 - 1.34), which suggest Bolt Biotherapeutics is a Sell
- The Bollinger Bands (100) for Bolt Biotherapeutics is (1.05 - 1.25), which suggest Bolt Biotherapeutics is a Sell
* Bolt Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.